InsidersTradesSigma
지투지바이오 Stock: price and insider trades · South Korea · DART (FSS)
Track the 지투지바이오 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 지투지바이오 has logged 24 public disclosures. Market capitalisation: €500.5bn. The latest transaction was filed on 22 May 2026 (Purchase). Among the most active insiders: 이희용. Every trade is accessible without an account.
24
Insider Decl.
n/a
Thresholds
€126,583
24 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 22 May 2026
Declarations24 total
24 of 24 declarations
About 지투지바이오
지투지바이오 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development of biopharmaceutical solutions.